Last reviewed · How we verify
NCT03596931
Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients
trial testing Statins (Cardiovascular Agents) in Acute Coronary Syndrome in 130 participants. Completed in 31 August 2018.
30 June 2018
Quick facts
| Lead sponsor | Tarumanagara University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 1 August 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 31 August 2018 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Statins (Cardiovascular Agents) — full drug profile →
Conditions studied
- Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
- Acute Pulmonary Edema — all drugs for Acute Pulmonary Edema →
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
- Heart Failure — all drugs for Heart Failure →
Sponsor
Tarumanagara University
Who can join
Eligibility, any sex, with Acute Coronary Syndrome or Acute Pulmonary Edema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of statin for primary prevention, towards lowering the incidence of heart failure, acute lung edema, malignant arrhythmia and death in ACS patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03596931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Statins (Cardiovascular Agents)
Trials testing the same drug.
- NCT05419583 — Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction · NA · completed
- NCT05565976 — Dapagliflozin Effect in Cognitive Impairment in Stroke Trial · Phase 2, PHASE3 · unknown
- NCT04426084 — Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study · unknown
- NCT04301336 — Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia · Phase 2, PHASE3 · completed
Other recruiting trials for Acute Coronary Syndrome
Currently open trials in the same condition.
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
- NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
- NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting
Other Tarumanagara University trials
Trials by the same sponsor.
- NCT07491978 — Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Heal · not yet recruiting
- NCT07502703 — Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurement · not yet recruiting
- NCT07502690 — Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c · not yet recruiting
- NCT05856292 — Improving Cancer Pain Management Through Teach-Back Educational Approach for Patients and Primary Caregivers: A Pilot St · NA · completed
- NCT03607201 — Acute Coronary Syndrome in Diabetic Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03596931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tarumanagara University
- Last refreshed: 12 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03596931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing